Some studies have found that the expression of CLPTM1L is significantly increased in lung cancer tissues compared with normal tissues by immunohistochemistry, especially in lung adenocarcinoma (Ni et al., 2012). Here, CLPTM1L is linked to lung adenocarcinoma.